Master the diagnostic complexities of hypertrophic cardiomyopathy (HCM) with Dr Sara Saberi, a leading expert in inherited cardiovascular diseases.
This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, provides essential insights into the nuanced approach required for accurate HCM diagnosis and risk stratification.
Dr Saberi addresses critical diagnostic considerations, including the importance of comprehensive clinical history and the need to differentiate HCM from other conditions that cause left ventricular hypertrophy. Drawing from real patient cases, Dr Saberi demonstrates the evolution of sudden cardiac death risk assessment, explaining how factors such as age at presentation, outflow tract obstruction severity, left atrial dilation, and ventricular arrhythmias contribute to risk stratification.
Key learning objectives include recognizing atrial fibrillation as a serious warning sign in young HCM patients, understanding when genetic testing adds clinical value, and developing expertise in comprehensive family screening strategies.
Stay tuned for more expert content from the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program.
About Women As One
Women As One is a global organization dedicated to empowering women in cardiology. They offer a variety of resources and programs, including the CLIMB Skills Training Program and the Women As One Talent Directory, a global community of women in cardiology.
Join the Women As One Community
Women physicians who are not yet part of the Women As One community can register for free here.
Comments